site stats

Cingulate ticker

WebApr 8, 2024 · Open an account. Provide your personal information and sign up. Fund your account. Deposit funds unto your account by linking your banking information or transfer … WebOct 4, 2024 · IPO details. Cingulate Inc. is slated to go public on Thursday, October 7. The company will begin trading on NASDAQ under the ticker symbol CING. It will offer 4.6 million shares at a price range of $10 to $12 to raise $50.1 million. The IPO will be managed by a group of underwriters led by Oppenheimer & Co.

ADHD medication firm Cingulate files for $58m IPO - Capital

WebFind the latest Cingulate Inc. (CING) stock quote, history, news and other vital information to help you with your stock trading and investing. See the company profile for Cingulate Inc. (CING) including business summary, … Discover historical prices for CING stock on Yahoo Finance. View daily, weekly or … Find the latest Cingulate Inc. (CING) stock discussion in Yahoo Finance's forum. … Get the detailed quarterly/annual income statement for Cingulate Inc. (CING). … Find out all the key statistics for Cingulate Inc. (CING), including valuation … View the basic CING option chain and compare options of Cingulate Inc. on … Find out the direct holders, institutional holders and mutual fund holders for … See Cingulate Inc. (CING) Environment, Social and Governance Ratings to help … See Cingulate Inc. (CING) stock analyst estimates, including earnings and … Trial On Track for 3Q 2024 Results Pivotal Phase 3 Trial in Pediatric/Adolescent … WebJan 20, 2024 · Latest News. Maxim Group analyst Naz Rahman maintained a Buy rating on Cingulate Inc (CING - Research Report) yesterday and set a price target of $3.00. The company's shares opened today at $0.96.According to TipRanks, Rahman is an analyst with an average return of -37.2% and a 17.65% success rate. Rahman covers the Healthcare … desert dog tires off road https://fourseasonsoflove.com

Cingulate Inc. (CING) - Yahoo Finance

WebDec 14, 2024 · Issuer Name and Ticker or Trading Symbol Cingulate Inc. [ CING] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X: Director: 10% Owner: Officer (give title below) ... WebSep 10, 2024 · Cingulate Inc filed for an IPO, penciling in a modest $58 million raise, and expects to list on NASDAQ under CING ticker. Cingulate has a Phase 3-ready attention deficit hyperactivity disorder ... WebOct 13, 2024 · Cingulate Therapeutics' IPO date and price. Cingulate is expected to start trading on Oct. 15. The company now plans to raise $40 million by offering 4.4 million … desert dog fountain hills

Tickeron on Twitter: "$CING in Downtrend: RSI indicator exits ...

Category:Cingulate Inc. (CING) Stock Price Today, Quote & News

Tags:Cingulate ticker

Cingulate ticker

IPO news: Cingulate is making its market debut this week

WebDec 15, 2024 · The current estimated net worth of Cingulate Inc's Director, Peter Werth, is estimated to be about $1.33M . Peter Werth owns about 997,014 units of Cingulate Inc … WebApr 11, 2024 · A high-level overview of Cingulate Inc. (CING) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Cingulate ticker

Did you know?

WebJan 25, 2024 · Cingulate Inc. (NASDAQ: CING), is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a ... WebApr 8, 2024 · Open an account. Provide your personal information and sign up. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account. Search for the stock name – CING. Search for the stock by name or ticker symbol. Buy the stock. Place your order.

WebApr 10, 2024 · Company Description. Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of … WebAnalyze quarterly positions in Cingulate with up to 7 years of data, all consolidated into one spreadsheet Download as csv Download as Excel Top investors of Cingulate stock

WebCingulate. Manufacturing · Kansas, United States · <25 Employees . Cingulate is a clinical stage biopharmaceutical company utilizing its proprietary Precision Timed Release drug … WebOct 4, 2024 · IPO details. Cingulate Inc. is slated to go public on Thursday, October 7. The company will begin trading on NASDAQ under the ticker symbol CING. It will offer 4.6 …

WebApr 10, 2024 · Get a real-time Cingulate Inc. (CING) stock price quote with breaking news, financials, statistics, charts and more. ... Ticker Symbol CING. Full Company Profile. …

WebMar 13, 2024 · Cingulate’s comprehensive agreement with Indegene covers most facets of the commercialization process, including sales, PRMA (pricing, reimbursement and market access), medical affairs, medical communications, pharmacovigilance, regulatory, marketing and commercial operations support. ... Börse aktuell - Live Ticker. Nach Fed-Protokoll: ... chthon\\u0027s vengeanceWebThe cingulate cortex is a part of the brain situated in the medial aspect of the cerebral cortex.The cingulate cortex includes the entire cingulate gyrus, which lies immediately above the corpus callosum, and the … desert downtownWebSep 10, 2024 · Cingulate Inc filed for an IPO, penciling in a modest $58 million raise, and expects to list on NASDAQ under CING ticker. Cingulate has a Phase 3-ready attention deficit hyperactivity disorder ... desert dreamer womens twotone sweatpantsWebDec 7, 2024 · Cingulate Inc. (“Cingulate” or the “Company”), today announced the pricing of its initial public offering of 4,166,666 shares of common stock and accompanying warrants to purchase 4,166,666 shares of common stock. ... The shares and warrants are scheduled to begin trading on the Nasdaq Capital Market under the ticker symbols “CING ... chthon powersWebSep 16, 2024 · It plans to trade under the ticker CING. Timed release. What makes Cingulate’s product different than those offered by competitors is that its product slowly releases medication throughout the day whereas other medicines take effect almost immediately and cause a “crash” later, according to the company’s prospectus. desert downtown grand rapidsWebDec 10, 2024 · Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next ... chthons powersWebMar 10, 2024 · Debt. Other. Inside Cingulate Inc.'s 10-K Annual Report: Financial - Expense Highlight. We have experienced, and will continue to experience, increased expenses associated with being a public company, including costs of accounting, audit, legal, regulatory and tax compliance services; director and officer insurance; and investor and … chthon\u0027s vengeance